Drug Delivery Devices Market Advancing Chronic Care Solutions

Revenue, 2025

USD 463.86 Billion

Forecast, 2035

USD 986.7 Billion

CAGR, 2026-2035

7.84%

Report Coverage

Global

Drug Delivery Devices Market Size, Insights and Key Players with Dynamics

The global drug delivery devices market size was estimated at USD 463.86 billion in 2025 and is predicted to increase from USD 500.23 billion in 2026 to approximately USD 986.7 billion by 2035, expanding at a CAGR of 7.84% from 2026 to 2035.

Due to a growth in diseases globally, the demand for effective treatment options is rising, promoting the use of various drug delivery devices. The growing investments and use of AI are accelerating their development and innovations. The presence of advanced healthcare, a large population, and technological advancements is also increasing their use across various regions. Moreover, the companies are also launching new devices, which is promoting the market growth.

Key Takeaways

• Drug delivery devices sector pushed the market to USD 500.23 billion by 2026.
• Long-term projections show USD 986.7 billion valuation by 2035.
• Growth is expected at a steady CAGR of 7.84% in between 2026 to 2035.
• North America dominated the drug delivery devices market in 2025.
• Asia Pacific is expected to be the fastest-growing region between 2026 and 2035.
• By product type, the inhalers segment dominated the market in 2025. 
• By product type, the injection devices segment is expected to be the fastest growing during the forecast period.
• By application type, the diabetes segment dominated the market in 2025.
• By application type, the central nervous system disorders segment is expected to be the fastest growing during the forecast period.
• By end use, the hospitals segment dominated the market in 2025.
• By end use, the diagnostic centers segment is expected to grow significantly during the forecast period.

Key Indicators and Highlights

What are the Drug Delivery Devices?

The drug delivery devices market is driven by growing demand for self-administered systems, increasing incidence of chronic conditions, and technical advancements. The drug delivery devices encompass the tools and systems offering accurate, controlled, and safe drug delivery to the patient. They are being used in the management of chronic diseases due to their targeted drug delivery, compatibility with unstable drug products, and delivery of advanced therapies.

What is the Use of AI in the Drug Delivery Devices Market?

The use of AI in drug delivery devices is increasing for patient treatment monitoring, where its predictive analytics help in detecting patient response. It is also used in the development of personalized solutions, with the use of patient data. It also helps in the optimization of these devices, promoting the development of improved and patient-friendly devices. AI is also being used to develop advanced devices, promoting their integration with telehealth platforms.

Trends & Future Outlook of the Drug Delivery Devices Market

Shift Towards Self-Administration

The growing chronic diseases and geriatric population are increasing the demand for home care drug products, which is increasing the use of self-administration devices, enhancing their convenience, treatment adherence, and comfort.

Blooming Smart Devices

Different types of smart devices are being developed, which enable tracking and monitoring of the treatment along with controlled drug delivery, enhancing patient adherence and successful treatment rates.

Focus on User-Friendly Devices

The companies are focusing on the development of patient-friendly devices with the development of small and portable devices offering easy drug administration along with fewer errors.

Segmental Insights

By Product  Insights

Why Did the Inhalers Segment Dominate in the Drug Delivery Devices Market in 2025?

The inhalers segment held the largest share in the market in 2025, due to the growth in the incidence of respiratory diseases. The inhalers also provided a rapid onset of action, which increased their adoption rates. Furthermore, their portability and non-invasive approach also increased their use.

Injection Devices

The injection devices segment is expected to show the highest growth during the predicted time, due to high bioavailability and rapid onset of action. Moreover, the growing development of biologics and advanced therapies is also increasing their demand. Additionally, the growing shift towards self-administration is also increasing their use.

By Application Insights

What Made Diabetes the Dominant Segment in the Drug Delivery Devices Market in 2025?

The diabetes segment led the market in 2025, due to growth in its incidence rates and health awareness. This, in turn, increased the demand for various drug delivery devices for effective treatment. Furthermore, the daily insulin administration and use of advanced therapies also increased the use of injectable devices.

Central Nervous System Disorders

The central nervous system disorders segment is expected to show the fastest growth rate during the upcoming years, driven by growth in CNS drug development and the growing number of disorders. This is increasing the demand for advanced drug delivery devices, where the investment from various sources is promoting their advancements.

By End Use Insights

Which End Use Type Segment Held the Dominating Share of the Drug Delivery Devices Market in 2025?

The hospitals segment held the dominating share in the market in 2025, due to high patient volume. The presence of skilled personnel and a variety of drug products also increased the use of various drug delivery devices. Additionally, reimbursement policies and emergency care are also increasing patient outcomes.

Diagnostic Centers

The diagnostic centers segment is expected to show significant growth during the predicted time, due to their advanced imaging technologies. At the same time, they also offer fast and accurate disease diagnosis. Additionally, their rapid expansion is also increasing the adoption of various devices.

Regional Insights

Well-Developed Healthcare Drives North America

North America dominated the drug delivery devices market in 2025, due to the presence of advanced healthcare, which increased its use. At the same time, the growing incidence of chronic diseases has also increased their adoption rates. Furthermore, the growing health awareness and R&D investment are also increasing their adoption and innovation, respectively, which contributed to the market growth.

U.S. Market Trends

The U.S consists of a well-developed healthcare sector, which is increasing the use of different types of drug delivery devices. The companies are also developing advanced technologies where the healthcare investment is accelerating their innovations. Additionally, increasing patient awareness is also increasing the use of self-administering devices.

Chronic Diseases Boost Asia Pacific

Asia Pacific is expected to host the fastest-growing drug delivery devices market during the forecast period, due to growing chronic diseases and a large population. The expanding healthcare is also increasing its adoption of various drug delivery devices, where the increasing government and private sector support is also increasing their innovation, enhancing the market growth.

China Market Trends

The presence of a large population is increasing the incidence of diabetes and other chronic diseases in China, which is increasing the use of various drug delivery devices. Additionally, the expanding healthcare sector and government initiatives are also increasing their use, enhancing their production rates.

Europe Driven by Increasing Innovations

Europe is expected to grow significantly in the drug delivery devices market during the forecast period, due to its growing advancements. The industries are focusing on the development of various drug delivery devices, where the growing shift towards home care is also increasing their use. Additionally, the increasing diseases and health awareness are also increasing their use, promoting the market growth.

UK Market Trends

The well-developed healthcare infrastructure in the UK is driving the demand for drug delivery devices, creating new opportunities. The growing diseases are also increasing their continuous use, where the growth in the development of advanced therapies and biologics is also increasing their use, which is supported by funding.

Drug Delivery Devices Market Value Chain Analysis

R&D

• The R&D of the drug delivery devices focuses on the development of smart devices, nanotechnologies, and wearable injectors.
• Key players: Becton Dickinson, Roche, Sanofi.

Clinical Trials and Regulatory Approvals

• Safety, therapeutic efficacy, and performance reliability are evaluated in the clinical trials and regulatory approval of the drug delivery devices.
• Key players: Medtronic, Roche, and Becton Dickinson.

Formulation and Final Dosage Preparation

• The formulation and final dosage preparation of the drug delivery devices involves optimization of chemical stability and physical compatibility between the drug and its primary container.
• Key players: Becton Dickinson, Gerresheimer.

Patient Support and Services

• Personalized training programs, 24/7 technical support, and digital companion apps are provided in the patient support and services of the drug delivery devices.
• Key players: Medtronic, Aptar Pharma, AbbVie.

Drug Delivery Devices Market Top Vendors and Their Offerings

SWOT Analysis

Strengths

• The drug delivery devices offer controlled and accurate drug delivery, which reduces the chances of errors and side effects.
• They also offer targeted delivery, which reduces the systemic side effects and increases the patient acceptance rates.
• They are also being used for the delivery of advanced therapies, which is increasing their demand.
• Moreover, their portability is also increasing their use, promoting patient convenience and home care applications.

Weaknesses

• High cost acts as the major weakness in the drug delivery devices market, which limits their acceptance rates.
• Limited availability and dosing errors reduce their use due to safety concerns.

Opportunities

• The growing incidence of chronic disease is increasing the use of a variety of drug delivery devices.
• The increasing advancements in biologics and biosimilars are also increasing their adoption rates.
• Growing health campaigns are also increasing the use of various injectables, which is increasing their production rates.
• Furthermore, the growing shift towards home care is also increasing the demand for self-administration devices.

Threats

• Stringent quality control and regulatory requirements slow down the innovations of the drug delivery devices.
• Rapid technological advancements also limit the R&D of various drug delivery devices.

What are the Recent Developments in the Drug Delivery Devices Market?

• In January 2026, a commitment of $30 million investment from Sanofi in Enable Injections, which is a company developing the enFuse syringe transfer system for drug delivery, was announced. This investment will be used to enhance the manufacturing build-out of the Enable Injections.
• In November 2025, an additional £1.5 million in seed funding was secured by 1nhaler, which is a drug delivery device developer, where the investment will be utilized to support its innovative platform technology.

Segments Covered in the Report

By Product

• Inhalers
  • Metered-dose inhalers (MDIs)
  • Dry powder inhalers (DPIs)
  • Others
• Injection Devices
  • Prefilled Syringes
  • Auto-injectors
  • Pen injectors
  • Needle-free injectors
  • Wearable injectors 
• Implants
  • Contraceptive implants
  • Drug-eluting stents
  • Biodegradable implants
• Topical Delivery System
  • Creams
  • Gels
  • Ointments
• Oral Delivery System
  • Controlled-release tablets and capsules
  • Buccal and sublingual tablets
  • Ocular Delivery System
  • Nebulizers
  • Transdermal Patches
• Infusion Pumps

By Application

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Others

By End Use

• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Others

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA